GHDX

Genomic Health, Inc.
GHDX

Overview Fund Activity
Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

112 hedge funds and large institutions have $901M invested in Genomic Health, Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 14 closing their positions.

Holders
112
Holders Change
-1
Holders Change %
-0.88%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
44
Reduced
30
Closed
14
Calls
$2.16M
Puts
$11M
Net Calls
-$8.84M
Net Calls Change
-$8.92M

Top Buyers

1
State Street
1
State Street
Massachusetts
$25.5M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$33M
3
MFWM
3
Motley Fool Wealth Management
Virginia
$5.33M
4
BC
4
Broadfin Capital
New York
$2.29M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$5.27M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.7M
2
Millennium Management
2
Millennium Management
New York
$8.72M
3
CIP
3
Champlain Investment Partners
Vermont
$30.8M
4
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$0
5
ICM
5
IronBridge Capital Management
Illinois
$11.4M
Name Market Value Shares Shares
Change 		Shares
Change %
TWA
126
TCI Wealth Advisors
Arizona
– – -160 Closed
2 3 4 5
6